effect of blood cells derived gel on tooth pain

EFFICACY OF PLATELET DERIVED GROWTH FACTOR GEL IN THE TREATMENT OUTCOME OF DENTINAL HYPERSENSITIVITY - A CLINICAL STUDY.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041893

Enrollment

Registered

2022-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Periodontal Flap Surgery: At Initial phase patient is recalled for every seven days for three weeks and application of Citric Acid Root Modifying Agent followed by Platelet Derived Grow

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Presence of maxillary or mandibular marginal tissue recession 2 . Age group is 18-60 yrs 3.systemically healthy patients

Exclusion criteria

Exclusion criteria: 1.systemically compromised patients. 2.using either homecare or inoffice desensitizing agents. 3.who underwent periodontal treatment last 6 months 4.opposing similar restorative material 5.dental carious lesion and endodontically treated tooth 6.non carious cervical lesions.

Design outcomes

Primary

Measure	Time frame
relative attachment level visual analog score schiff sensitivity scoreTimepoint: baseline and 1 month	—

Secondary

Measure	Time frame
sensitivity reductionTimepoint: 1month	—

Countries

India

Contacts

Public ContactLanger Swetha

Kaloji Narayana Rao University, warangal

drjagadishreddy@gmail.com9949801470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026